SurModics to Present at the InvestMNt Conference

July 22, 2013 at 8:01 AM EDT

Webcast is Live on Thursday, August 1, at 8:30 a.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jul. 22, 2013-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and chief financial officer, will make a presentation to the investment community at the 2013 InvestMNt conference on Thursday, August 1, 2013, at 8:30 a.m. CT (9:30 a.m. ET) in Minneapolis, MN.

A live audio webcast of the presentation will be available on Thursday, August 1, by going to the investor relations portion of the Company’s website at and clicking on the webcast icon. In addition, the audio and slide presentation will be archived on the Company’s website following the meeting.

About SurModics, Inc.
SurModics’ mission is to exceed our customers’ expectations and enhance patients’ well-being by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. SurModics partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.

Source: SurModics, Inc.

SurModics, Inc.
Andy LaFrence, 952-500-7000